Literature DB >> 25135763

Factors influencing treatment of atypical hemolytic uremic syndrome.

Carla M Nester1, Richard J H Smith2.   

Abstract

Entities:  

Keywords:  complement; genetic renal disease; hemolytic uremic syndrome

Mesh：

Substances：

Year:  2014        PMID： 25135763      PMCID： PMC4152814          DOI： 10.2215/CJN.07540714

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  39 in total

1.  Atypical hemolytic-uremic syndrome in a child presenting with malignant hypertension.

Authors:  Alisha Totina; Franca Iorember; Samir S El-Dahr; Ihor V Yosypiv
Journal:  Clin Pediatr (Phila)       Date:  2011-06-27       Impact factor: 1.168

2.  Three kidneys, two diseases, one antibody?

Authors:  Nolwenn Lorcy; Nathalie Rioux-Leclercq; Marie-Laure Lombard; Patrick Le Pogamp; Cécile Vigneau
Journal:  Nephrol Dial Transplant       Date:  2011-08-03       Impact factor: 5.992

3.  Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1).

Authors:  Diogo Bento; Joana Mapril; Carla Rocha; Kevin J Marchbank; David Kavanagh; Dawn Barge; Lisa Strain; Timothy H J Goodship; Carlos Meneses-Oliveira
Journal:  Ren Fail       Date:  2010-07       Impact factor: 2.606

4.  Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.

Authors:  Tara K Maga; Carla J Nishimura; Amy E Weaver; Kathy L Frees; Richard J H Smith
Journal:  Hum Mutat       Date:  2010-06       Impact factor: 4.878

5.  Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies.

Authors:  John Chapin; Stephen Eyler; Richard Smith; Han-Mou Tsai; Jeffrey Laurence
Journal:  Blood       Date:  2013-05-09       Impact factor: 22.113

6.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.

Authors:  Véronique Fremeaux-Bacchi; Fadi Fakhouri; Arnaud Garnier; Frank Bienaimé; Marie-Agnès Dragon-Durey; Stéphanie Ngo; Bruno Moulin; Aude Servais; François Provot; Lionel Rostaing; Stéphane Burtey; Patrick Niaudet; Georges Deschênes; Yvon Lebranchu; Julien Zuber; Chantal Loirat
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-10       Impact factor: 8.237

7.  Is complement factor H a susceptibility factor for IgA nephropathy?

Authors:  Matthew Edey; Lisa Strain; Roy Ward; Saeed Ahmed; Trevor Thomas; Timothy H J Goodship
Journal:  Mol Immunol       Date:  2009-01-21       Impact factor: 4.407

8.  Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Authors:  Sonata Jodele; Tsuyoshi Fukuda; Alexander Vinks; Kana Mizuno; Benjamin L Laskin; Jens Goebel; Bradley P Dixon; Ashley Teusink; Fred G Pluthero; Lily Lu; Christoph Licht; Stella M Davies
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-25       Impact factor: 5.742

9.  Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.

Authors:  Mathieu Lemaire; Véronique Frémeaux-Bacchi; Franz Schaefer; Murim Choi; Wai Ho Tang; Moglie Le Quintrec; Fadi Fakhouri; Sophie Taque; François Nobili; Frank Martinez; Weizhen Ji; John D Overton; Shrikant M Mane; Gudrun Nürnberg; Janine Altmüller; Holger Thiele; Denis Morin; Georges Deschenes; Véronique Baudouin; Brigitte Llanas; Laure Collard; Mohammed A Majid; Eva Simkova; Peter Nürnberg; Nathalie Rioux-Leclerc; Gilbert W Moeckel; Marie Claire Gubler; John Hwa; Chantal Loirat; Richard P Lifton
Journal:  Nat Genet       Date:  2013-03-31       Impact factor: 41.307

10.  Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura.

Authors:  John-Paul Westwood; Kathryn Langley; Edward Heelas; Samuel J Machin; Marie Scully
Journal:  Br J Haematol       Date:  2013-12-28       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.